Free Trial

Bath & Body Works, Inc. (NYSE:BBWI) Short Interest Update

Bath & Body Works logo with Retail/Wholesale background
Remove Ads

Bath & Body Works, Inc. (NYSE:BBWI - Get Free Report) was the recipient of a significant growth in short interest during the month of February. As of February 28th, there was short interest totalling 6,000,000 shares, a growth of 31.0% from the February 13th total of 4,580,000 shares. Based on an average daily volume of 4,010,000 shares, the short-interest ratio is currently 1.5 days. Approximately 2.8% of the company's stock are sold short.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of BBWI. SRS Capital Advisors Inc. lifted its stake in shares of Bath & Body Works by 99.7% during the 4th quarter. SRS Capital Advisors Inc. now owns 659 shares of the company's stock worth $26,000 after acquiring an additional 329 shares during the last quarter. Golden State Wealth Management LLC purchased a new stake in Bath & Body Works in the fourth quarter worth $26,000. UMB Bank n.a. lifted its position in shares of Bath & Body Works by 58.8% during the fourth quarter. UMB Bank n.a. now owns 905 shares of the company's stock worth $35,000 after purchasing an additional 335 shares during the last quarter. Lindbrook Capital LLC boosted its stake in shares of Bath & Body Works by 81.9% during the fourth quarter. Lindbrook Capital LLC now owns 957 shares of the company's stock valued at $37,000 after purchasing an additional 431 shares during the period. Finally, Smartleaf Asset Management LLC grew its holdings in shares of Bath & Body Works by 135.0% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,013 shares of the company's stock worth $39,000 after purchasing an additional 582 shares during the last quarter. Institutional investors own 95.14% of the company's stock.

Remove Ads

Analyst Ratings Changes

A number of equities analysts recently issued reports on the stock. Citigroup upgraded shares of Bath & Body Works from a "neutral" rating to a "buy" rating and upped their price target for the stock from $40.00 to $48.00 in a research note on Friday, February 28th. Robert W. Baird lifted their target price on shares of Bath & Body Works from $45.00 to $47.00 and gave the stock an "outperform" rating in a research report on Friday, February 28th. Morgan Stanley cut their price objective on Bath & Body Works from $51.00 to $48.00 and set an "overweight" rating for the company in a report on Thursday, November 21st. Cowen reissued a "buy" rating on shares of Bath & Body Works in a report on Thursday, February 27th. Finally, Barclays dropped their price target on shares of Bath & Body Works from $43.00 to $38.00 and set an "equal weight" rating on the stock in a research note on Monday, March 3rd. Five research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $45.06.

Get Our Latest Research Report on BBWI

Bath & Body Works Trading Up 0.5 %

Shares of BBWI stock traded up $0.14 on Friday, reaching $30.24. The company's stock had a trading volume of 42,058,293 shares, compared to its average volume of 4,264,684. The stock's fifty day simple moving average is $35.83 and its 200-day simple moving average is $33.93. Bath & Body Works has a 1 year low of $26.21 and a 1 year high of $52.99. The company has a market capitalization of $6.48 billion, a price-to-earnings ratio of 7.38, a price-to-earnings-growth ratio of 0.92 and a beta of 1.89.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings data on Thursday, February 27th. The company reported $2.09 EPS for the quarter, topping analysts' consensus estimates of $2.04 by $0.05. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The business had revenue of $2.79 billion during the quarter, compared to analysts' expectations of $2.78 billion. Equities research analysts forecast that Bath & Body Works will post 3.3 earnings per share for the current year.

Bath & Body Works declared that its board has approved a stock repurchase program on Thursday, February 27th that permits the company to buyback $500.00 million in shares. This buyback authorization permits the company to repurchase up to 6.4% of its shares through open market purchases. Shares buyback programs are typically a sign that the company's leadership believes its shares are undervalued.

Bath & Body Works Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 7th. Stockholders of record on Friday, February 21st were given a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 2.65%. The ex-dividend date of this dividend was Friday, February 21st. Bath & Body Works's dividend payout ratio is currently 21.98%.

About Bath & Body Works

(Get Free Report)

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

Featured Articles

Should You Invest $1,000 in Bath & Body Works Right Now?

Before you consider Bath & Body Works, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.

While Bath & Body Works currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads